In her Sept. 11 Outlook essay, “Tackling most cancers whereas battling the insurance coverage system,” Annabelle Gurwitch described a drug-pricing rip-off. Why isn’t the secretary of well being and human companies testifying in Congress about these shady and complicated practices?
Given these practices, how will the administration have the ability to reach attaining President Biden’s promise to decrease the price of medication? Pharmacy profit managers, co-pay accumulators and their maximizer packages have created a very complicated system with no transparency. HHS is just not doing the job residents want.